Compare SANA & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SANA | ROOT |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.1M | 943.7M |
| IPO Year | 2021 | 2020 |
| Metric | SANA | ROOT |
|---|---|---|
| Price | $3.29 | $61.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $7.80 | ★ $92.40 |
| AVG Volume (30 Days) | ★ 2.8M | 199.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.24 | ★ 28.96 |
| EPS | N/A | ★ 2.09 |
| Revenue | N/A | ★ $1,517,100,000.00 |
| Revenue This Year | N/A | $11.73 |
| Revenue Next Year | N/A | $12.80 |
| P/E Ratio | ★ N/A | $28.54 |
| Revenue Growth | N/A | ★ 28.95 |
| 52 Week Low | $2.61 | $40.91 |
| 52 Week High | $6.55 | $129.53 |
| Indicator | SANA | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 55.64 |
| Support Level | $3.03 | $55.53 |
| Resistance Level | $3.41 | $64.17 |
| Average True Range (ATR) | 0.21 | 2.80 |
| MACD | -0.05 | -0.31 |
| Stochastic Oscillator | 23.30 | 50.37 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.